Series C Pharmaceutical Companies

Loyal is a clinical-stage veterinary medicine company dedicated to extending the healthy lifespan of senior dogs.

Hemab is a clinical-stage biotech company that develops prophylactic biologic therapies for underserved bleeding and thrombotic.

Tubulis generates antibody-drug conjugates with unique properties for solid tumor indications.

SelectION is a clinical-stage biopharmaceutical company developing novel peptide therapies for autoimmune diseases

Phlow supplies affordable, quality, essential medicines through U.S.-based advanced manufacturing processes.

PolyActiva develops products that enable drug release from medical devices.

Arine uses AI to optimize medication therapy, improving patient outcomes and reducing healthcare costs for payers and providers.

Pin Therapeutics is a pharmaceutical startup focusing on advanced protein degradation therapeutics.

Nusano is a physics firm that produces radioisotopes, tiny tracers doctors use to diagnose and cure cancer and other ailments.

ImmunOs Therapeutics is a clinical-stage biotechnology company.

Bluejay Therapeutics is a private biopharmaceutical company focused on the development of cures for infectious diseases.

Aizon is a cloud-based SaaS platform that helps optimize industrial processes in biotech and pharma.

Prism is a biotechnology company that develops therapeutic drugs that cure intractable diseases using unique peptide mimic technology.

LB Pharmaceuticals specializes in developing LB-102 (n-Methyl amisulpride) as a treatment for schizophrenia.

Accent Therapeutics is a biopharmaceutical company.

SmithRx is reinventing PBMs with modern technology, client alignment, and 100% transparency.

Atomwise develops artificial intelligence systems using powerful deep learning algorithms and supercomputers for drug discovery.

Kanaph Therapeutics is a leading biotech in oncology, auto-immune, and eye diseases with large molecules and small molecules.

Koya Medical is a transformative healthcare company developing breakthrough treatments for lymphedema and venous diseases.

MitrAssist offers a minimally invasive approach to mitral regurgitation treatment.

Cullgen is a drug discovery services intended to create new drugs for the treatment of diseases that currently lack effective therapies.

Antheia uses synthetic biology to produce biosynthetic KSMs and APIs for essential medicines through engineered microbial fermentation.

Nuclera offers a protein prototyping system to accelerate drug discovery by making proteins readily available to researchers.

Aspen Neuroscience is a biotechnology company that specializes in personalized cell therapies and autologous regenerative medicine.